| Engineering exosomes as refined biological nanoplatforms for drug delivery X Luan, K Sansanaphongpricha, I Myers, H Chen, H Yuan, D Sun Acta Pharmacologica Sinica 38 (6), 754-763, 2017 | 963 | 2017 |
| Isorhamnetin: A review of pharmacological effects G Gong, YY Guan, ZL Zhang, K Rahman, SJ Wang, S Zhou, X Luan, ... Biomedicine & Pharmacotherapy 128, 110301, 2020 | 299 | 2020 |
| Combating COVID-19 with integrated traditional Chinese and Western medicine in China L Ni, L Chen, X Huang, C Han, J Xu, H Zhang, X Luan, Y Zhao, J Xu, ... Acta Pharmaceutica Sinica B 10 (7), 1149-1162, 2020 | 158 | 2020 |
| Mesoporous silica nanoparticles: Facile surface functionalization and versatile biomedical applications in oncology R Huang, YW Shen, YY Guan, YX Jiang, Y Wu, K Rahman, LJ Zhang, ... Acta Biomaterialia 116, 1-15, 2020 | 105 | 2020 |
| Synergistic mechanisms of constituents in herbal extracts during intestinal absorption: Focus on natural occurring nanoparticles Q Zhao, X Luan, M Zheng, XH Tian, J Zhao, WD Zhang, BL Ma Pharmaceutics 12 (2), 128, 2020 | 98 | 2020 |
| Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer F Bai, C Wang, Q Lu, M Zhao, FQ Ban, DH Yu, YY Guan, X Luan, YR Liu, ... Biomaterials 34 (26), 6163-6174, 2013 | 92 | 2013 |
| Compound-based Chinese medicine formula: From discovery to compatibility mechanism X Luan, LJ Zhang, XQ Li, K Rahman, H Zhang, HZ Chen, WD Zhang Journal of ethnopharmacology 254, 112687, 2020 | 84 | 2020 |
| Targeting KRAS mutant cancers: from druggable therapy to drug resistance C Zhu, X Guan, X Zhang, X Luan, Z Song, X Cheng, W Zhang, JJ Qin Molecular Cancer 21 (1), 159, 2022 | 79 | 2022 |
| The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination J Jin, Y Wu, J Chen, Y Shen, L Zhang, H Zhang, L Chen, H Yuan, H Chen, ... Theranostics 10 (22), 10141, 2020 | 74 | 2020 |
| Selective eradication of tumor vascular pericytes by peptide-conjugated nanoparticles for antiangiogenic therapy of melanoma lung metastasis YY Guan, X Luan, JR Xu, YR Liu, Q Lu, C Wang, HJ Liu, YG Gao, ... Biomaterials 35 (9), 3060-3070, 2014 | 70 | 2014 |
| Raddeanin A, a triterpenoid saponin isolated from Anemone raddeana, suppresses the angiogenesis and growth of human colorectal tumor by inhibiting VEGFR2 signaling YY Guan, HJ Liu, X Luan, JR Xu, Q Lu, YR Liu, YG Gao, M Zhao, HZ Chen, ... Phytomedicine 22 (1), 103-110, 2015 | 67 | 2015 |
| Albumin nanoparticle of paclitaxel (Abraxane) decreases while taxol increases breast cancer stem cells in treatment of triple negative breast cancer H Yuan, H Guo, X Luan, M He, F Li, J Burnett, N Truchan, D Sun Molecular pharmaceutics 17 (7), 2275-2286, 2020 | 64 | 2020 |
| Brucine: a review of phytochemistry, pharmacology, and toxicology L Lu, R Huang, Y Wu, JM Jin, HZ Chen, LJ Zhang, X Luan Frontiers in Pharmacology 11, 377, 2020 | 64 | 2020 |
| Tumor priming using metronomic chemotherapy with neovasculature-targeted, nanoparticulate paclitaxel X Luan, YY Guan, JF Lovell, M Zhao, Q Lu, YR Liu, HJ Liu, YG Gao, ... Biomaterials 95, 60-73, 2016 | 56 | 2016 |
| Integrated combination treatment using a “smart” chemotherapy and microrna delivery system improves outcomes in an orthotopic colorectal cancer model HJ Liu, X Luan, HY Feng, X Dong, SC Yang, ZJ Chen, QY Cai, Q Lu, ... Advanced Functional Materials 28 (28), 1801118, 2018 | 54 | 2018 |
| Ginsenoside Rd: A promising natural neuroprotective agent YY Chen, QP Liu, P An, M Jia, X Luan, JY Tang, H Zhang Phytomedicine 95, 153883, 2022 | 53 | 2022 |
| Targeting CTGF in cancer: an emerging therapeutic opportunity YW Shen, YD Zhou, HZ Chen, X Luan, WD Zhang Trends in cancer 7 (6), 511-524, 2021 | 51 | 2021 |
| Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway X Luan, YG Gao, YY Guan, JR Xu, Q Lu, M Zhao, YR Liu, HJ Liu, C Fang, ... Toxicology and applied pharmacology 281 (1), 118-124, 2014 | 47 | 2014 |
| Antiangiogenic triterpenes isolated from Chinese herbal medicine Actinidia chinensis Planch WJ Zhu, DH Yu, M Zhao, MG Lin, Q Lu, QW Wang, YY Guan, GX Li, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2013 | 45 | 2013 |
| Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation X Luan, H Yuan, Y Song, H Hu, B Wen, M He, H Zhang, Y Li, F Li, P Shu, ... Biomaterials 275, 120910, 2021 | 43 | 2021 |
Duxin Sun, PhDAssociate Dean for Research and the Charles Walgreen Jr. Professor at the College of Pharmacy, UMVerified email at umich.edu
